What the new NHS Norfolk and Suffolk ICB means for you

A newly merged NHS body now oversees healthcare planning for around 1.7 million people across Norfolk and Suffolk – here is what changed today and why it matters.

A doctor with a patient
A doctor with a patient (Photo: Daisy-Daisy/Getty Images)

Why it matters: NHS Suffolk and North East Essex Integrated Care Board (ICB) and NHS Norfolk and Waveney ICB have been abolished and replaced by a single new organisation – NHS Norfolk and Suffolk ICB (N&S ICB) – which became operational on Wednesday, 1 April 2026. The body is now responsible for planning and commissioning all NHS services across the entirety of Norfolk and Suffolk.

The details: The reorganisation is part of the government's 10 Year Health Plan. Under the changes, responsibility for the Colchester and Tendring areas of Essex – previously part of NHS Suffolk and North East Essex ICB – has transferred to a separate new body, NHS Essex ICB, which also became operational on 1 April 2026.

The N&S ICB is chaired by Professor William Pope, with Dr Ed Garratt serving as chief executive. The board includes health and care professionals with experience across NHS executive leadership, primary care, acute hospital management, voluntary-sector leadership, system transformation, and clinical practice.

What they're saying: Dr Garratt said: "The creation of this new organisation marks an exciting moment for our system. By bringing together talented and experienced professionals from across Norfolk and Suffolk, we have a real opportunity to strengthen partnerships, deepen collaboration, and make better use of our shared expertise. Working as one, we can drive meaningful improvements in health and wellbeing for the communities we serve across both counties."

What's next: The N&S ICB held its first public board meeting on Wednesday, 1 April at 10:00, streamed live on YouTube.

The bottom line: Suffolk's NHS commissioning has moved from two separate bodies to a single merged organisation spanning two counties. Whether the merger translates into tangible improvements for patients remains to be seen.

This article cost us ~£21 to produce

It's free for you to read thanks to the generous support of our partners. Please support us by supporting them.

Below the line